Literature DB >> 15297549

V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa.

Leonard R Allmond1, Temitayo Ajayi, Kiyoshi Moriyama, Jeanine P Wiener-Kronish, Teiji Sawa.   

Abstract

The pcrV genotype was analyzed in clinical isolates of Pseudomonas aeruginosa which showed a negative phenotype for secretion of V-antigen PcrV. The suppression of PcrV secretion in these isolates was due not to a lack of the pcrV gene but rather to suppression of PcrV expression.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15297549      PMCID： PMC497603          DOI： 10.1128/JCM.42.8.3857-3860.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway.

Authors:  Matthew C Wolfgang; Vincent T Lee; Meghan E Gilmore; Stephen Lory
Journal:  Dev Cell       Date:  2003-02       Impact factor: 12.270

2.  Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon.

Authors:  Denis Dacheux; Olivier Epaulard; Arjan de Groot; Benoit Guery; Rozen Leberre; Ina Attree; Benoit Polack; Bertrand Toussaint
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis.

Authors:  T W BURROWS; G A BACON
Journal:  Br J Exp Pathol       Date:  1958-06

4.  Analyses of the DNA-binding and transcriptional activation properties of ExsA, the transcriptional activator of the Pseudomonas aeruginosa exoenzyme S regulon.

Authors:  A K Hovey; D W Frank
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

5.  Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections.

Authors:  A Roy-Burman; R H Savel; S Racine; B L Swanson; N S Revadigar; J Fujimoto; T Sawa; D W Frank; J P Wiener-Kronish
Journal:  J Infect Dis       Date:  2001-05-17       Impact factor: 5.226

6.  Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.

Authors:  N Shime; T Sawa; J Fujimoto; K Faure; L R Allmond; T Karaca; B L Swanson; E G Spack; J P Wiener-Kronish
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

Authors:  Alan R Hauser; Enesha Cobb; Maria Bodi; Dolors Mariscal; Jordi Vallés; Joanne N Engel; Jordi Rello
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

8.  Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.

Authors:  Heather Feltman; Grant Schulert; Salman Khan; Manu Jain; Lance Peterson; Alan R Hauser
Journal:  Microbiology       Date:  2001-10       Impact factor: 2.777

9.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.

Authors:  C K Stover; X Q Pham; A L Erwin; S D Mizoguchi; P Warrener; M J Hickey; F S Brinkman; W O Hufnagle; D J Kowalik; M Lagrou; R L Garber; L Goltry; E Tolentino; S Westbrock-Wadman; Y Yuan; L L Brody; S N Coulter; K R Folger; A Kas; K Larbig; R Lim; K Smith; D Spencer; G K Wong; Z Wu; I T Paulsen; J Reizer; M H Saier; R E Hancock; S Lory; M V Olson
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

10.  Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.

Authors:  Dara W Frank; Amy Vallis; Jeanine P Wiener-Kronish; Arup Roy-Burman; Edward G Spack; Brian P Mullaney; Mehdi Megdoud; James D Marks; Robert Fritz; Teiji Sawa
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226
View more
  4 in total

1.  Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV - implications for anti-PcrV immunotherapy.

Authors:  Susan V Lynch; Judith L Flanagan; Teiji Sawa; Alice Fang; Marshall S Baek; Amua Rubio-Mills; Temitayo Ajayi; Katsunori Yanagihara; Yoichi Hirakata; Shigeru Kohno; Benoit Misset; Jean-Claude Nguyen; Jeanine P Wiener-Kronish
Journal:  Microb Pathog       Date:  2010-03-06       Impact factor: 3.738

2.  Intrinsic and Extrinsic Regulation of Type III Secretion Gene Expression in Pseudomonas Aeruginosa.

Authors:  Manisha R Diaz; Jessica M King; Timothy L Yahr
Journal:  Front Microbiol       Date:  2011-04-25       Impact factor: 5.640

3.  In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses.

Authors:  Jonathon P Audia; Ashley S Lindsey; Nicole A Housley; Courtney R Ochoa; Chun Zhou; Michie Toba; Masahiko Oka; Naga S Annamdevula; Meshann S Fitzgerald; Dara W Frank; Diego F Alvarez
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

4.  Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection.

Authors:  Mingzi Jiang; Jing Yao; Ganzhu Feng
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.752
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.